← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
DEF 14ADEF 14AApr 27, 2026DEF 14ADEF 14AApr 29, 2025DEF 14ADEF 14AApr 29, 2024DEF 14ADEF 14AApr 28, 2023DEF 14ADEF 14AMay 2, 2022DEF 14ADEF 14AMay 3, 2021DEF 14ADEF 14AMay 13, 2020DEF 14ADEF 14AMay 16, 2019DEF 14ADEF 14AApr 1, 2019DEF 14ADEF 14AApr 30, 2018DEF 14ADEF 14AApr 28, 2017DEF 14ADEF 14AApr 20, 2016DEF 14ADEF 14AApr 30, 2015DEF 14ADEFINITIVE PROXY STATEMENTApr 30, 2014DEF 14AFORM DEF 14AApr 30, 2013
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance